Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
597 |
|
| Actual shortage: | 85 (14%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 494 (83%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (74%) | |
| Reversed: | 11 (16%) | |
Late reports |
53 (8%) |
|
Overdue reports |
49 (52%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-22 | 2024-01-30 | 202687 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-22 | 2024-01-30 | 211052 |
| DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-07-31 | 2023-12-02 | 200468 |
| DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2024-03-11 | 2024-04-23 | 221877 |
| ELETRIPTAN | 20MG | TABLET | Resolved | 2024-12-02 | 2025-01-30 | 244298 |
| ELETRIPTAN | 20MG | TABLET | Resolved | 2024-10-07 | 2024-11-28 | 239491 |
| ENALAPRIL | 16MG | TABLET | Resolved | 2018-03-13 | 2018-05-23 | 42549 |
| ENALAPRIL | 4MG | TABLET | Resolved | 2018-04-02 | 2018-05-23 | 44405 |
| ENALAPRIL | 2MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73668 |
| ENALAPRIL | 4MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73671 |
| ENALAPRIL | 8MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73674 |
| ENALAPRIL | 16MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73677 |
| ESCITALOPRAM | 20MG | TABLET | Actual shortage | 2025-04-01 | 2025-04-10 | 253771 |
| ESCITALOPRAM | 20MG | TABLET | Resolved | 2025-01-13 | 2025-03-20 | 247540 |
| ESCITALOPRAM | 10MG | TABLET | Resolved | 2024-05-28 | 2024-08-01 | 228992 |
| ESCITALOPRAM | 10MG | TABLET | Resolved | 2024-09-24 | 2025-01-03 | 238396 |
| ESCITALOPRAM | 10MG | TABLET | Resolved | 2021-06-09 | 2021-07-18 | 140601 |
| ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-03-19 | 2024-06-06 | 222742 |
| ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-06-09 | 2021-07-15 | 140604 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-30 | 2024-02-09 | 217837 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |